With the aim of streamlining the regulatory process for biopharmaceutical manufacturers engaged in vaccine, recombinant DNA, ...

DBT clarifies that lower risk GE experiments can approach drug regulator with IBSC approval: Gireesh Babu, New Delhi Tuesday, September 9, 2025, 08:00 Hrs [IST] The biopharmaceuti ...

Learn how multichain biotherapeutics overcome manufacturing challenges with advanced expression vector design.

According to Coherent Market Insights (CMI), the global protein therapeutics market size is projected to expand at a CAGR of ...

LIYAM CHITAYAT is a Hertz Fellow and MIT Ph.D. student in Computational Systems Biology. She has previously led biodefense ...

The global Ligase Enzymes Market, valued at US$0.25 billion in 2024, stood at US$0.26 billion in 2025 and is projected to advance at a resilient ...

tebu-bio offers recombinant protein production services using a robust, inexpensive and fast transient-expression system in Chinese hamster ovary (CHO) cells, for various research and development ...

Strauss Group will launch cow-free milk and cheese with Imagindairy's whey protein in Israel, which is made from microbes via ...

This expansion represents a robust Compound Annual Growth Rate (CAGR) of approximately 11.20% during the forecast period from 2025 to 2034. This remarkable growth is fueled by a confluence of factors: ...

Next-generation sequencing enhances a biologics manufacturer's ability to detect and identify unknown or unexpected contaminants.

Molecular Biology Techniques: DNA cloning – plasmid vectors, and restriction enzymes; Polymerase Chain Reaction; Expression of cloned eukaryotic genes in bacteria; Hybridization techniques; DNA ...

The global Viral Vaccines CDMO Market is set to expand from USD 2.23 billion in 2024 to USD 7.39 billion by 2033, growing at a 15.1% CAGR. This growth is fueled by rising outsourced vaccine production ...